CVE-2026-31013: Dovestones Softwares ADPhonebook <4.0.1.1 has a reflected cross-site scripting (XSS) vulnerability in the sear
CVE-2026-31013 is a medium-severity flaw (CVSS 6.1) affecting ad phonebook. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Dovestones Softwares ADPhonebook <4.0.1.1 has a reflected cross-site scripting (XSS) vulnerability in the search parameter of the /ADPhonebook?Department=HR endpoint. User-supplied input is reflected in the HTTP response without proper input validation or output encoding, allowing execution of arbitrary JavaScript in the victim's browser.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.3% (top 77%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2026-04-21 |
| Last modified | 2026-10-24 |
Last updated 2026-10-24 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-31013?
ad phonebook: upgrade to 4.0.1.1. Exact commands for each OS are on this page.
Is CVE-2026-31013 being exploited?
CVE-2026-31013 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-31013 affect?
CVE-2026-31013 affects ad phonebook. Severity is medium (CVSS 6.1). Dovestones Softwares ADPhonebook <4.0.1.1 has a reflected cross-site scripting (XSS) vulnerability in the search parameter of the /ADPhonebook?Department=HR endpoint. User-supplied input is reflected in the HTTP response without proper inpu
How urgent is CVE-2026-31013?
Priority 27/100. No elevated risk signals yet.